Braveheart Bio, Inc. (BRVE) Ownership Overview
The ownership structure of Braveheart Bio, Inc. (BRVE) stock is a mix of institutional, retail, and individual investors. , 67.10% is owned by Insiders, and 32.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 11, 2026 | xxxxxxxxxxxxx | $34920000 | |
Aug 11, 2026 | xxxxxxxxxxxxx | $34920000 | |
Aug 11, 2026 | xxxxxxxxxxxxx | $19800000 | |
Aug 07, 2026 | xxxxxxxxxxxxx | $64800000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 21,826,024 | Insider | 28.59% | 583,627,882 | |
| 10,232,420 | Insider | 13.40% | 273,614,911 | |
| 8,333,637 | Insider | 10.92% | 222,841,453 | |
| 7,420,091 | Insider | 9.72% | 198,413,233 | |
| 1,013,297 | Insider | 1.33% | 27,095,562 | |
| 759,857 | Insider | 1.00% | 20,318,576 | |
| 703,575 | Insider | 0.92% | 18,813,596 | |
| 332,161 | Insider | 0.44% | 8,881,985 | |
| 273,333 | Insider | 0.36% | 7,308,924 | |
| 273,333 | Insider | 0.36% | 7,308,924 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,800 | Institution | 0.02% | 344,960 | |
| 3,698 | Institution | <0.01% | 97,183 |
FAQ
Who Owns Braveheart Bio, Inc. (BRVE)?
Currently, no data Available
What percentage of Braveheart Bio, Inc. (BRVE) stock is held by institutional investors?
Currently, no data Available
What percentage of Braveheart Bio, Inc. (BRVE) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.88% of Braveheart Bio, Inc. (BRVE) stock is held by retail investors.
Who owns the most shares of Braveheart Bio, Inc. (BRVE)?
Forbion Growth Opportunities Fund III Cooperatief owns the most shares of Braveheart Bio, Inc. (BRVE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.